Brand Intelligence Graph
Company Overview
About Retro Biosciences
Retro Biosciences is the largest-funded pure-play longevity company in history, raising $1 billion in Series A financing at a $5 billion valuation with Sam Altman (OpenAI CEO) as a primary backer. The company is pursuing cellular reprogramming, autophagy enhancement, and plasma factor therapeutics in parallel — a multi-pronged approach to extending healthy human lifespan by targeting the cellular hallmarks of aging simultaneously.
Business Model & Competitive Advantage
The $5B valuation with zero clinical data reflects extraordinary conviction from tech-founder capital that biological aging is fundamentally a solvable engineering problem. Retro is preparing its first human trial, targeted to launch in Australia, which will be a pivotal test of the cellular reprogramming hypothesis in vivo. The company works with leading academic researchers in aging biology and benefits from Sam Altman's network for scientific talent recruitment.
Competitive Landscape 2025–2026
Retro's approach is distinctively ambitious: rather than targeting a single disease or aging pathway, it is attempting to reverse the fundamental epigenetic aging clock that drives age-related decline across all tissues. If successful, this would represent a paradigm shift from disease treatment to genuine biological rejuvenation — a category of medicine that does not yet have an approved product anywhere in the world.
Key Differentiators
Emerging Innovator
Retro Biosciences is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare Retro Biosciences with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Retro Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Retro Biosciences Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Retro Biosciences vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →